LINAFEXOR
LIVE

Serial Number

79427316

Owner

Cascade Pharmaceuticals, Inc

Attorney

Priscilla Lauren Speer

Filing Date

May 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LINAFEXOR Trademark

Serial Number: 79427316 • Registration: 8268547

LINAFEXOR is a trademark filed by Cascade Pharmaceuticals, Inc on May 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Cascade Pharmaceuticals, Inc (6 trademarks)

Building 10,

Entity Type: 03

Trademark Details

Filing Date

May 27, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 25, 2026 ADCH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2026 TROA
REFUSAL PROCESSED BY IB
Oct 31, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 13, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 13, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 28, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 27, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 10, 2025 REPR